Certified by Founder Lodge
Omnes
France - Paris
INVESTOR
1 Disclosed Funding Rounds $10,000,000
16 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Powering entrepreneurship
Omnes, a leading European direct investor in private equity and infrastructure.
With €5 billion in assets under management and over 20 years of investment expe
| Company | Date | Round | Raised |
|---|---|---|---|
 SeqOne Genomics |
January, 24 ,2022 | Series A | $22,600,000 |
 Qantev |
October, 25 ,2022 | Series A | $10,000,000 |
 DiogenX |
May, 11 ,2023 | Series A | $30,056,125 |
 GOURMEY |
October, 05 ,2022 | Series A | $48,000,000 |
 Iktos |
March, 10 ,2023 | Series A | $16,428,000 |
 Sekoia.io |
May, 25 ,2023 | Series A | $37,561,000 |
 AlgoTx |
March, 15 ,2023 | Series B | $21,157,000 |
 Corteria Pharmaceuticals |
September, 07 ,2023 | Series A | $69,471,000 |
| SeqOne Genomics |
January, 24 ,2022 | Series A | $22,600,000 |
 Quantum-Systems |
October, 25 ,2023 | Series B | $63,309,000 |
| DiogenX |
May, 11 ,2023 | Series A | $30,056,125 |
 Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
| Sekoia.io |
May, 25 ,2023 | Series A | $37,561,000 |
| Corteria Pharmaceuticals |
September, 07 ,2023 | Series A | $69,471,000 |
| Quantum-Systems |
October, 25 ,2023 | Series B | $63,309,000 |
| Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
